A detailed history of Belvedere Trading LLC transactions in Novartis Ag stock. As of the latest transaction made, Belvedere Trading LLC holds 3,817 shares of NVS stock, worth $400,021. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,817
Previous 3,817 -0.0%
Holding current value
$400,021
Previous $439,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$106.13 - $120.89 $139,985 - $159,453
1,319 Added 52.8%
3,817 $439,000
Q2 2024

Nov 01, 2024

SELL
$92.57 - $107.37 $122,099 - $141,621
-1,319 Reduced 34.56%
2,498 $265,000
Q2 2024

Aug 09, 2024

SELL
$92.57 - $107.37 $401,198 - $465,341
-4,334 Reduced 63.44%
2,498 $265,000
Q1 2024

May 09, 2024

SELL
$95.27 - $108.47 $755,872 - $860,600
-7,934 Reduced 53.73%
6,832 $660,000
Q4 2023

Feb 13, 2024

BUY
$92.27 - $101.54 $1.36 Million - $1.5 Million
14,766 New
14,766 $1.49 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $225B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.